PSI Newsletter 2023

Read the updates and insights in the PSI Newsletter: Issue 1, 2023

• Notice of pharmacist candidates for Council election
• Pharmacist involvement in vaccination programmes
• Workforce project update
• Participation in HEA Advisory Panel
• Learning from a PSI Inquiry
• Patient consultation areas - compliance reminder
• Codeine guidelines reminder
• Empowering all pharmacists to deliver antimicrobial stewardship
• Core Competency Framework update
• Fitness to Practise outcomes
• Updates to vaccination and emergency medicines training information
• NIO training module approved for Comirnaty 3 mcg/dose
• PSI online services - reducing paper/digital first approach
• Benzodiazepine and Z-Drug resources
• Recap of recent emails from PSI to registrants

Read the updates and insights in the PSI Newsletter: Issue 2, 2023

• PSI governance updates: appointments to the PSI Council, PSI meeting with the Minister for Health
• Publication of reform of Pharmacy Act position paper
• Update on Emerging Risks to Future Pharmacy Workforce project and report approval
• PSI welcomes HEA report on building capacity in higher education for pharmacy programmes
• Learning from a PSI inquiry
• Fitness to Practise outcomes
• Approval of CPD model for pharmaceutical assistants
• Valproate (Epilim▼) materials for patients
• Medication errors when labelling products
• COVID-19 Immunisation Programme Update
• Steps to take for change of supervising pharmacist
• Update on bank details for registration payments
• Internet Supply List moving online
• Our Annual Report 2022 and Corporate Strategy extension
• Core Competency Framework for Pharmacists
• PSI events survey- have your say
• Recruitment: Disciplinary Committee membership and career opportunities with PSI
• Making a Protected Disclosure

Read the updates and insights in the PSI Newsletter: Issue 3, 2023

• Launch of the Workforce Intelligence Report
• Department of Health Expert Taskforce to support the expansion of the role of pharmacists
• Findings of specialist surveyor exercise on codeine products
• Vaccination Guidance 2023/2024
• COVID-19 and Seasonal Influenza vaccination information
• Fitness to Practise and Mediation Outcomes
• Single Use Plastics – Advice for Pharmacy Owners and Pharmacy Purchasing
• Safe sales of paracetamol - new information campaign
• Antimicrobial Resistance - useful resources
• Development of PSI’s ICT Strategy 2024-2027 - Survey
• Information on applications and renewal for Internet Supply List
• Recruitment: Vacancy for a Strategic Policy and Research Coordinator

Read the updates and insights in the PSI Newsletter: Issue 4, 2023

• End of Year Message from the Registrar
• Update on the Expert Taskforce to Support the Expansion of  Pharmacist Roles
• PSI Pharmacist Workforce Survey 2023
• Extension of the Children’s Flu Vaccination Programme 2023/24
• Approval of the HSE’s National Immunisation Office training in respect of Nuvaxovid XBB.1.5 vaccine
• ePortfolio Review 2023/2024 Reminder
• Antimicrobial Resistance-Resources and Training for Pharmacists 
• Repackaging of Solpadeine Soluble Tablets™ (60 pack) for Sale to Patients and the Public
• Inspection Insights from 2023
• Findings from Investigations in 2023
• Inspections Focused on Vaccination Services
• Ireland's first World Breastfeeding Trends Initiative assessment report
• Fitness to Practise and Mediation Outcomes